Langerhans cell histiocytosis: Difference between revisions
No edit summary |
Mahshid |
||
| (20 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
'''For patient information, click [[Langerhans cell histiocytosis (patient information)|here]]''' | '''For patient information, click [[Langerhans cell histiocytosis (patient information)|here]]''' | ||
{{Langerhans cell histiocytosis}} | {{Langerhans cell histiocytosis}} | ||
{{CMG}} | {{CMG}};{{AE}} | ||
{{SK}} Histiocytosis X; | {{SK}} Histiocytosis X; Histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; Eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; Non-lipid reticuloendotheliosis; Eosinophilic granuoloma; Pulmonary histiocytosis X; Pulmonary Langerhans cell granulomatosis | ||
==[[Langerhans cell histiocytosis overview|Overview]]== | ==[[Langerhans cell histiocytosis overview|Overview]]== | ||
| Line 60: | Line 29: | ||
==Treatment== | ==Treatment== | ||
[[Langerhans cell histiocytosis medical therapy|Medical Therapy]] | [[Langerhans cell histiocytosis surgery|Surgery]] | [[Langerhans cell histiocytosis primary prevention|Primary Prevention]] | [[Langerhans cell histiocytosis secondary prevention|Secondary Prevention]] | [[Langerhans cell histiocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Langerhans cell histiocytosis future or investigational therapies|Future or Investigational Therapies]] | [[Langerhans cell histiocytosis medical therapy|Medical Therapy]] | [[Langerhans cell histiocytosis surgery|Surgery]] | [[Langerhans cell histiocytosis primary prevention|Primary Prevention]] | [[Langerhans cell histiocytosis secondary prevention|Secondary Prevention]] | [[Langerhans cell histiocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Langerhans cell histiocytosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[Langerhans cell histiocytosis case study one|Case #1]] | |||
==Related chapters== | ==Related chapters== | ||
| Line 71: | Line 43: | ||
{{Hematology}} | {{Hematology}} | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 79: | Line 49: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:09, 27 November 2017
For patient information, click here
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:
Synonyms and keywords: Histiocytosis X; Histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; Eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; Non-lipid reticuloendotheliosis; Eosinophilic granuoloma; Pulmonary histiocytosis X; Pulmonary Langerhans cell granulomatosis
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Langerhans cell histiocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History amd Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies